NDC 51759-960 – Uzedy
Risperidone 250 mg/.7mL · Injection, Suspension, Extended Release · Subcutaneous
Product NDC51759-960
Product details
- Brand name
- Uzedy
- Generic name
- risperidone
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Subcutaneous
- Marketing category
- NDA · NDA213586
- Marketed since
- May 1, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Risperidone 250 mg/.7mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51759-960-10 | 1 SYRINGE, GLASS in 1 CARTON (51759-960-10) / .7 mL in 1 SYRINGE, GLASS | May 1, 2023 |
| 51759-960-11 sample | 1 SYRINGE, GLASS in 1 CARTON (51759-960-11) / .7 mL in 1 SYRINGE, GLASS | May 1, 2023 |
Other Uzedy products
- 51759-305 Risperidone 50 mg/.14mL · Injection, Suspension, Extended Release · Teva Pharmaceuticals USA, Inc.
- 51759-410 Risperidone 75 mg/.21mL · Injection, Suspension, Extended Release · Teva Pharmaceuticals USA, Inc.
- 51759-520 Risperidone 100 mg/.28mL · Injection, Suspension, Extended Release · Teva Pharmaceuticals USA, Inc.
- 51759-630 Risperidone 125 mg/.35mL · Injection, Suspension, Extended Release · Teva Pharmaceuticals USA, Inc.
- 51759-740 Risperidone 150 mg/.42mL · Injection, Suspension, Extended Release · Teva Pharmaceuticals USA, Inc.
- 51759-850 Risperidone 200 mg/.56mL · Injection, Suspension, Extended Release · Teva Pharmaceuticals USA, Inc.